NORWAY - Ferd could realise historic returns if Pronova Biocare is up for sale

Ferd Private Equity is reported to be in the process of putting Pronova Biocare up for sale. Ferd acquired the pharmaceutical company in Jannuary 2004 for NOK 530m. Artic Securities, the newly established Norwegian ivestment bank, has now valued the company at NOK 15bn. With these valuations, Norwegian press anticipates Ferd to realise a NOK 14bn representing potential historic returns for the Norwegian investor.